PML and cancer: Several normal cells and 10% to 15% of cancer cells elongate their telomeres via the ALT mechanism that is based on DNA homologous recombination (5, 7, 8) ALT cells have significantly heterogeneous telomeres in length (between 3 kb and 50 kb), and they contain ALT-associated promyelocytic leukemia (PML) body (APB).